Compramos VALEANT o es una TRAMPA ?

Shares of  Valeant Pharmaceuticals (VRX) rallied more than 6% Monday, following a Real Money report that activist short seller Andrew Left has reversed his investment tack on the beleagured drugmaker. Left carries remarkable market clout when it comes to Valeant, largely because his bearish take proved accurate last fall, and contributed to a steep selloff in … More Compramos VALEANT o es una TRAMPA ?